Recombinant Expression of Lymphocytic Choriomeningitis Virus Strain WE Glycoproteins: a Single Amino Acid Makes the Difference
Open Access
- 15 January 2001
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 75 (2) , 1061-1064
Abstract
Cytoplasmic vector systems are generally used for expression of lymphocytic choriomeningitis virus (LCMV) proteins. However, we achieved high levels of cell surface glycoproteins using a standard nuclear expression plasmid. Expression was independent of other LCMV proteins but was blocked by a missense mutation within the original LCMV(WE) glycoprotein cDNA.Keywords
This publication has 19 references indexed in Scilit:
- Identification of α-Dystroglycan as a Receptor for Lymphocytic Choriomeningitis Virus and Lassa Fever VirusScience, 1998
- Fibroblasts as Efficient Antigen-Presenting Cells in Lymphoid OrgansScience, 1995
- Protein-protein interactions in lymphocytic choriomeningitis virusVirology, 1991
- Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic miceCell, 1991
- Vaccination for DiseaseScience, 1991
- Anti‐viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia‐recombinant virus expressing LCMV‐WE nucleoprotein or glycoproteinEuropean Journal of Immunology, 1989
- Expression of the S-coded Genes of Lymphocytic Choriomeningitis Arenavirus Using a Baculovirus VectorJournal of General Virology, 1986
- Complete sequence of the S RNA of lymphocytic choriomeningitis virus (WE strain) compared to that of pichinde arenavirusVirus Research, 1985
- Lymphocytic choriomeningitis virus. VI. Isolation of a glycoprotein mediating neutralizationVirology, 1983
- Lymphocytic Choriomeningitis Virus. V. Proposed Structural Arrangement of Proteins in the VirionJournal of General Virology, 1983